openPR Logo
Press release

Osteoarthritis Drugs Market Size is Anticipated to Reach USD 17.7 Billion, Growing at a CAGR of 8.5% by 2031 | TMR Research

07-31-2024 01:26 PM CET | Health & Medicine

Press release from: Transparency Market Research

Osteoarthritis Drugs Market

Osteoarthritis Drugs Market

Osteoarthritis (OA) is the most common form of arthritis, affecting millions of people worldwide. It is a degenerative joint disease characterized by the breakdown of cartilage, leading to pain, stiffness, and impaired movement. The increasing prevalence of osteoarthritis, driven by aging populations and rising obesity rates, underscores the growing demand for effective treatments. This article explores the current state, trends, and future prospects of the osteoarthritis drugs market.

Osteoarthritis Drugs Market (골관절염 약물 시장) is expected to grow at a CAGR of 8.5% from 2023 to 2031 and reach US$ 17.7 Bn by the end of 2031

Request a PDF Sample of this Report Now!
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=47571

Overview of Osteoarthritis Drugs Market
The global osteoarthritis drugs market is expanding due to advancements in pharmacological treatments, increasing research and development activities, and a growing focus on improving the quality of life for patients. The market is segmented by drug type (analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, viscosupplementation agents, disease-modifying osteoarthritis drugs (DMOADs), others), route of administration (oral, topical, injectable), distribution channel (hospital pharmacies, retail pharmacies, online pharmacies), and geographical regions.

Top Companies:

Horizon Pharma plc
Pfizer Inc.
Sanofi
Anika Therapeutics, Inc.
Ferring B.V.
Bioventus, Inc.
Chugai Pharmaceutical Industries Ltd.
Alkem Laboratories
Flexion Therapeutics, Inc.
Zimmer Biomet Holdings, Inc.

Recent Developments in Osteoarthritis Drugs Market
Recent advancements and trends in the osteoarthritis drugs market include:

Disease-Modifying Osteoarthritis Drugs (DMOADs): Development of DMOADs aiming to slow disease progression and modify the underlying pathology of osteoarthritis.
Biologic Therapies: Introduction of biologic therapies targeting specific pathways involved in inflammation and cartilage degradation.
Gene Therapy: Exploration of gene therapy approaches to promote cartilage regeneration and repair damaged joint tissues.
Combination Therapies: Increasing use of combination therapies that incorporate multiple mechanisms of action to enhance treatment efficacy.
Personalized Medicine: Growth in personalized medicine approaches to tailor osteoarthritis treatments based on individual patient profiles and genetic factors.

Drivers of Market Growth
Several factors contribute to the growth of the osteoarthritis drugs market:

Rising Prevalence: Increasing prevalence of osteoarthritis, particularly among the aging population, driving the demand for effective treatments.
Sedentary Lifestyles: Sedentary lifestyles and rising obesity rates contributing to the higher incidence of osteoarthritis.
Advancements in Treatment Options: Continuous advancements in pharmacological treatments enhancing the efficacy and safety of osteoarthritis drugs.
Increased Awareness: Growing awareness about osteoarthritis and the importance of early diagnosis and treatment among healthcare professionals and patients.
Research and Development: Active research and development efforts leading to the discovery of new therapeutic targets and treatment modalities.

Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=47571

Conclusion

The osteoarthritis drugs market is poised for significant growth, driven by rising prevalence, advancements in treatment options, increased awareness, and active research and development efforts. Innovations in DMOADs, biologic therapies, gene therapy, combination therapies, and personalized medicine are enhancing the potential and efficacy of osteoarthritis treatments.

Market Segmentation

Drug Class
Corticosteroids
NSAIDs & Others
Viscosupplementation Agents

Route of Administration
Oral
Parenteral
Topical

Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Regions Covered
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=47571<ype=S

More Trending Reports by Transparency Market Research -

Urinary Tract Disorders Propels Ureteral Stents Market (尿路疾患が尿管ステント市場を牽引): https://www.globenewswire.com/news-release/2024/07/05/2909009/32656/en/Rising-Incidence-of-Urinary-Tract-Disorders-Propels-Ureteral-Stents-Market-to-Achieve-USD-823-7-Million-by-2031-Transparency-Market-Research-Inc.html

Cryotherapy Market (Marché de la cryothérapie): https://www.globenewswire.com/en/news-release/2024/07/03/2908096/32656/en/Cryotherapy-Market-to-be-Worth-USD-885-7-million-by-2034-Growing-a-CAGR-9-3-Exclusive-Report-by-Transparency-Market-Research-Inc.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Osteoarthritis Drugs Market Size is Anticipated to Reach USD 17.7 Billion, Growing at a CAGR of 8.5% by 2031 | TMR Research here

News-ID: 3605663 • Views:

More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 - Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth. Uncover essential discoveries and trends from
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Radiopharmaceuticals to Propel Market Expansion | Transparency Market Research, Inc
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth. Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100 Analysts' Viewpoint The Technetium‐99m
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to US$ 280 Million by 2030, Driven by Rising Equine Diseases and Diagnostic Advancements
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of 6.1%
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,

All 5 Releases


More Releases for Osteoarthritis

Osteoarthritis Market Massive Growth opportunity Ahead
Introduction Osteoarthritis (OA), the most common form of arthritis, remains a significant global health burden, causing pain, mobility limitations, and reduced quality of life for millions. Driven by an aging population, lifestyle-related factors like obesity, and a growing focus on musculoskeletal health, the osteoarthritis market is witnessing notable transformation. According to Exactitude Consultancy, the global osteoarthritis market was valued at USD 14 billion in 2024 and is projected to reach USD 22
Rising Sports Injuries Fuel Growth In Osteoarthritis Therapeutics Market: The Dr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Osteoarthritis Therapeutics Market Size Growth Forecast: What to Expect by 2025? In recent times, the osteoarthritis therapeutics market has seen substantial growth. The market size was $8.17 billion in 2024 and is projected to rise to $8.87 billion in 2025, reflecting an annual compound growth rate (CAGR) of 8.6%.
Osteoarthritis Treatment Market Trends and Forecast 2034
On March 20, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Osteoarthritis Treatment Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across
Osteoarthritis Treatment Market
Introduction Osteoarthritis (OA) is the most common form of arthritis, affecting millions worldwide. It is a degenerative joint disease that primarily impacts the cartilage and causes pain, stiffness, and reduced mobility. The growing prevalence of osteoarthritis, especially among the aging population, has created a significant demand for treatment options. The osteoarthritis treatment market includes various therapeutic approaches, such as medications, physical therapies, and surgical procedures, designed to manage the symptoms and
Osteoarthritis Therapeutics Market - Finding Freedom from Osteoarthritis: Discov …
Newark, New Castle, USA: The "Osteoarthritis Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Osteoarthritis Therapeutics Market: https://www.growthplusreports.com/report/osteoarthritis-therapeutics-market/7779 This latest report researches the industry structure, sales, revenue,
Osteoarthritis Therapeutics Market: Rising Obese and Geriatric Populations to In …
Industry is experiencing significant growth due to the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market. What the Osteoarthritis Therapeutics Market Looks Like? The osteoarthritis therapeutics market is projected to reach USD 10.1 billion by 2024 from USD 6.8